NT-3

N/A

Report date: 2024/12/03 14:06:25

Base Information

Drug NameNT-3
Drug Alias NameNeurotrophin-3NT3Neurotrophic factor-3Recombinant human neurotrophic factorNT-3
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionNeurotrophin-3 ligand
TargetsNeurotrophin-3
Therapy Area/IndicationsConstipationDiabetic NeuropathiesPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen IncTakeda Pharmaceutical Co LtdRegeneron Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsConstipationDiabetic NeuropathiesPeripheral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksWikipedia